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Malaria burden and costs of intensiﬁ ed control in Bhutan, 
2006–14: an observational study and situation analysis
Kinley Wangdi, Cathy Banwell, Michelle L Gatton, Gerard C Kelly, Rinzin Namgay, Archie C A Clements
Summary
Introduction The number of malaria cases has fallen in Bhutan in the past two decades, and the country has a goal of 
complete elimination of malaria by 2016. The aims of this study are to ascertain the trends and burden of malaria, the 
costs of intensiﬁ ed control activities, the main donors of funding for the control activities, and the costs of diﬀ erent 
preventive measures in the pre-elimination phase (2006–14) in Bhutan.
Methods We undertook a descriptive analysis of malaria surveillance data from 2006 to 2014, using data from the 
Vector-borne Disease Control Programme (VDCP) run by the Department of Public Health of Bhutan’s Ministry of 
Health. Malaria morbidity and mortality in local Bhutanese people and foreign nationals were analysed. The cost of 
diﬀ erent control and preventive measures were calculated, and the average numbers of long-lasting insecticidal nests 
per person were estimated.
Findings A total of 5491 conﬁ rmed malaria cases occurred in Bhutan between 2006 and 2014. By 2013, there was an 
average of one long-lasting insecticidal net for every 1·51 individuals. The cost of procuring long-lasting insecticidal 
nets accounted for more than 90% of the total cost of prevention measures. The Global Fund to Fight AIDS, 
Tuberculosis and Malaria was the main international donor, accounting for more than 80% of the total funds.
Interpretation The malaria burden in Bhutan decreased signiﬁ cantly during the study period with high coverage of 
long-lasting insecticidal nets. The foreseeable challenges that require national attention to maintain a malaria-free 
status after elimination are importation of malaria, especially from India; continued protection of the population in 
endemic districts through complete coverage with long-lasting insecticidal nets and indoor residual spraying; and 
exploration of local funding modalities post-elimination in the event of a reduction in international funding.
Funding None.
Copyright © Wangdi et al. Open Access article distributed under the terms of CC BY.
Introduction
Bhutan is one of more than 30 countries with a stated goal 
of malaria elimination.1 Bhutan has endorsed the goal of 
an Asia-Paciﬁ c region free of malaria by 2030 and is one 
of 18 countries pursuing this goal through membership of 
the Asia-Paciﬁ c Malaria Elimination Network.2 The Vector-
borne Disease Control Programme (VDCP), run by the 
Department of Public Health of Bhutan’s Ministry of 
Health, aims to eliminate malaria by 2016 and obtain 
WHO certiﬁ cation of elimination by 2020.3
Malaria transmission in Bhutan occurs in seven of 
20 districts (ﬁ gure 1). Malaria-endemic districts have a 
subtropical climate with hot and humid conditions and 
abundant rainfall during the monsoon period, which 
lasts up to 3 months.4 Plasmodium falciparum and P vivax 
are the main malaria parasite species in Bhutan and the 
main vector species are Anopheles pseudowillmori and 
A culicifacies.3,5
A malaria eradication programme was ﬁ rst established 
in Bhutan in 1964. However, following a rapid increase in 
cases, Bhutan transitioned to a malaria control 
programme from 1971 to 1995. This increase might have 
been caused by a reduction in the frequency of indoor 
residual spraying from three times a year during 1965–74 
to twice a year from 1974, the coverage of which also fell 
from 80% in 1973 to below 50% in 1974.6 Moreover, active 
case detection was initiated in 1969 and continued until 
1989, meaning that a higher proportion of cases was 
identiﬁ ed, thereby increasing the number of cases 
recorded.7 From 1996 to 2003, Bhutan began to reinvest 
in malaria control activities with goals of improved access 
to remote and rural areas and diﬃ  cult-to-reach 
populations, initiating cross-border prevention and 
increasing awareness of malaria.8 In 2004–14, control and 
preventive measures focused on the scale-up of control 
and preventive measures in high-risk areas.
The main control and preventive measure during the 
eradication era (1964–71) was indoor residual spraying 
with dichlorodiphenyltrichloroethane (DDT); however, 
because of reports of resistance to DDT in some areas of 
the world, global concern over its environmental eﬀ ects 
and safety, and reduced public acceptance, DDT was 
replaced by deltamethrin (a synthetic pyrethroid) from 
1995 to 1997.4,9,10 In 1998, insecticide-treated bednets were 
introduced, as a result of the Roll Back Malaria initiative, 
which aimed to rely on personal protection sustained by 
community involvement and participation.7 In 2003, 
focal indoor residual spraying was introduced for use 
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during outbreaks and emergencies and in areas of high 
P falciparum transmission with an annual parasite 
incidence higher than 10 per 1000 population.11 In 2006, 
the existing preventive approach was initiated, using 
long-lasting insecticidal nets and two rounds of indoor 
residual spraying every year (ﬁ gure 2).
Malaria control activities are decentralised and 
integrated into the general health-care system in Bhutan. 
Microscopic diagnostic facilities for examination of blood 
for malaria parasites are available to all health facilities in 
endemic areas. Rapid diagnostic tests are used when 
microscopists are not available (out of hours) or during 
outbreaks or emergencies when the demand for 
microscopy is high. Treatment for P vivax malaria has 
not changed since 1965, and remains chloroquine for 
3 days and primaquine over 14 days (ﬁ gure 2), whereas 
treatment options for P falciparum malaria have changed 
over the years, and are presently artemether–
lumefantrine and quinine (ﬁ gure 2).
Malaria surveillance in Bhutan is done through passive 
case detection and fever surveillance, which involves 
submitting numbers of fever cases at the end of each 
week to the VDCP from the ﬁ eld through district oﬃ  ces. 
The latter is an important ongoing surveillance method—
an increase of fever cases over the weekly mean of the 
preceding 5 years triggers an investigation of a possible 
outbreak of malaria. A spatial decision support system 
based on geographic information systems (GIS) has 
been set up to help surveillance in malaria-reporting 
districts.7
This study is a situation observational analysis, deﬁ ned 
as an assessment of the present health situation, which is 
fundamental to designing and updating national policies, 
strategies, and plans.12 We aimed to determine the trends 
and burden of malaria, the costs of intensiﬁ ed control 
activities, the main donors of the control activities, and 
the costs of diﬀ erent preventive measures in the pre-
elimination phase (2006–14).
Methods
Study design and data collection
We obtained nationwide data about malaria cases in 
Bhutan from 2006 to 2014 from the national malaria 
surveillance system, hosted by the VDCP. These data 
contained laboratory-conﬁ rmed malaria cases, which 
were deﬁ ned as clinically diagnosed cases with either 
malaria parasites conﬁ rmed by microscopy or a positive 
rapid diagnostic test result. Since all health services in 
Bhutan are free of charge with good coverage and no 
private practices, we can assume that this dataset is 
complete for clinical malaria cases. Additionally, every 
health centre in malaria-endemic areas has dedicated 
malaria technicians who are able to monitor fever cases 
in their small catchments, thus increasing the likelihood 
of fever cases being tested for malaria. The infections 
were categorised by species: P falciparum and P vivax or 
mixed infections. The following patient information was 
extracted for each case: whether the patient was a 
Bhutanese citizen or a foreign national (foreign nationals 
were classiﬁ ed as non-Bhutanese citizens visiting or 
residing in Bhutan), age, occupation, and sex.
Historical information was obtained through searches of 
databases such as PubMed, MEDLINE, and Google 
Scholar, using the search terms “Bhutan”, “malaria 
elimination”, “long-lasting insecticidal nets”, and “indoor 
residual spraying” between Feb 1, 2015, and March 30, 
2016. Search was not restricted to published studies, but 
included conference presentations, abstracts, and 
government reports. No language restrictions were 
imposed.
Research in context
Evidence before this study
We searched PubMed for relevant articles using “malaria” AND 
“Bhutan” as search terms with no speciﬁ ed start date up to 
Feb 25, 2016, and with no language restrictions. Our search 
identiﬁ ed 22 studies, of which 14 speciﬁ cally related to malaria. 
Two studies described malaria control in Bhutan. Both reports 
draw attention to importation of malaria across Indian states as 
a critical issue. One paper outlined Bhutan’s plan to screen at 
border points and major construction sites with expatriate 
workers, to prevent importation of malaria.
Added value of this study
The study presents a detailed analysis of the trends of malaria in 
the pre-elimination period in Bhutan with regard to types of 
infection, age-speciﬁ c and sex-speciﬁ c burden, occupation, 
deaths, and the nationality of patients with malaria. It further 
analyses the costs associated with malaria elimination, 
incorporating sources of funding for scale-up of activities 
leading to pre-elimination. Cost analysis studied individual 
control and preventive measures including long-lasting 
insecticidal nets, indoor residual spraying, drugs, and other 
commodities. Additionally, the ratio of long-lasting insecticidal 
net coverage per person over three mass distribution periods 
was presented.
Implications of all the available evidence
The risk of importation of malaria from India necessitates 
coordinated malaria control activities between India and 
Bhutan. Additionally, populations in the malaria-endemic 
districts will need complete coverage with long-lasting 
insecticidal nets and indoor residual spraying. Local funding 
modalities post-elimination of malaria need to be explored if a 
reduction in international funding occurs. Initiation of 
public–private partnerships in cost sharing and social 
marketing of long-lasting insecticidal nets is one possible way 
forward.
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Malaria indicators
The total number of long-lasting insecticidal nets 
distributed from 2006 to 2014 was obtained from the 
VDCP. Long-lasting insecticidal nets were distributed to 
all the population residing in 36 subdistricts of seven 
districts. These subdistricts were selected based on the 
presence of malaria vectors. The average number of 
people per net was calculated for the years 2006, 2010, 
and 2013 (the mass distribution years) using the 
corresponding population of the 36 subdistricts. 
Population estimates used in this study were from 
publications from the National Statistical Bureau and 
the Oﬃ  ce of the Census Commissioner of Bhutan 
(estimates of uncertainty regarding the population are 
not available).13,14
Test positivity rate was calculated by dividing the total 
number of malaria cases by the number of blood slide 
examinations and rapid diagnostic tests used, multiplied 
by 100 (and expressed as a percentage). Annual malaria 
incidence was calculated as the annual cumulative 
incidence of malaria cases reported by each district 
divided by the total population of the districts of the same 
year, multiplied by 1000.
Cost analysis
Data about the funds disbursed to the VDCP from 
international donors (The Global Fund to Fight AIDS, 
Tuberculosis, and Malaria; WHO; and the Government 
of India), and from the Royal Government of Bhutan, 
were obtained from the VDCP for the 2008–14 ﬁ nancial 
years. The costs of diﬀ erent commodities such as drugs, 
long-lasting insecticidal nets, chemicals and equipment 
(eg, pumps) for indoor residual spraying, microscopes, 
and rapid diagnostic tests, were obtained from the VDCP. 
All the funds were converted into US dollars (US$) for 
analysis. Costs were analysed based on diﬀ erent 
preventive measures, running of programme oﬃ  ces, and 
fuel for vehicles.
Statistical analysis and ethics clearance
Data were extracted into Microsoft Excel and Stata 12.1 
was used for statistical analysis. Permission to use the 
data was approved by the Ministry of Health of the Royal 
Government of Bhutan. Since the datasets did not 
contain information about individual patients, ethical 
clearance was not required.
Role of the funding source
There was no funding source for this study. The 
corresponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results
During the 9 years from 2006 to 2014, a total of 
5491 cases of malaria were reported in Bhutan. Malaria 
in Bhutanese citizens accounted for 4377 cases: 80% of 
the total. In the Bhutanese population, the highest 
number of malaria cases was reported in 2006 with 
1751 cases, followed by 883 cases in 2009. The lowest 
number of cases was 21 cases in 2014. In 2006, mono-
infections with P vivax accounted for 895 (52%) of 
Figure 1: Map of Bhutan showing malaria-reporting districts and subdistricts
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1751 cases, followed by P falciparum (733 [42%]) and 
mixed infections (124 [7%]). In 2014, P falciparum 
infected 11 (52%) of the 21 cases, and there were no 
mixed infections (table 1, ﬁ gure 3).
Two types of foreign national status were recorded in 
the malaria patient records in Bhutan. The ﬁ rst group of 
foreigners includes those staying in Bhutan on a longer-
term basis, mostly Indians working in developmental 
projects; the second category includes Indian nationals 
visiting Bhutan on day visits for business and 
employment. Malaria in the foreign nationals residing 
in Bhutan accounted for 384 (7%) of the total cases 
(table 1). In 2006, 116 cases were reported in this group, 
with numbers decreasing to 21 (6%) of 384 cases in 2014. 
Malaria in foreign national daily visitors accounted for 
730 cases (13% of the total) during the study period. The 
highest number of cases reported in foreign national 
daily visitors was in 2006 (408 cases). After this 
timepoint, a decreasing trend occurred, with just three 
cases in 2014. Most of the infections were caused by 
P falciparum throughout the study period, with the 
exception of 2013, when P vivax was more frequent than 
P falciparum. No mixed infections were reported in 
foreign national daily visitors since 2011. Overall, foreign 
nationals (both those residing in Bhutan and daily 
visitors) contributed more than half of all malaria cases 
since 2013 (table 1).
A total of 15 deaths were recorded during the study 
period. The highest numbers of deaths were reported in 
2006 and 2009, with four (27%) deaths each. No deaths 
have been reported since 2013. All deaths were caused 
by P falciparum or mixed infections (table 1). Women 
accounted for the most deaths (ten) and there were four 
deaths in children. Samdrup Jongkhar district reported 
the highest number of deaths (ﬁ ve), followed by Sarpang 
district (three).
Malaria indicators showed that numbers of blood 
samples collected for testing malaria parasites decreased 
during the study period, as did the test positivity rate 
(table 1). Annual malaria incidence fell during the study 
period from 12·9 cases per 1000 population in 2006 to less 
than one case per 1000 population from 2012 to 2014 
(table 1).
During the study period, 357 091 new long-lasting 
insecticide-treated nets were distributed to residents in 
36 subdistricts in endemic districts. In 2006, 93 269 were 
distributed, achieving an average of one long-lasting 
insecticidal net per 1·44 people. In 2010 and 2013, 99 697 
and 99 617 long-lasting insecticidal nets were distributed, 
with averages of one net per 1·45 people in 2010 and one 
per 1·51 people in 2013. Follow-up distributions of long-
lasting insecticidal nets were continued in the years 
between mass distributions as a mechanism to achieve 
universal population coverage (table 1).
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Treatment 
options
Chloroquine and primaquine
Chloroquine and 
primaquine
Sulfadoxine, 
quinine, and 
primaquine
Artesunate, doxycycline, 
and quinine
Artemether–lumefantrine, 
and quinine
Plasmodium vivax
Plasmodium falciparum
Preventive methods Indoor 
residual
spraying*
Indoor 
residual
spraying
†
Indoor 
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‡ and 
insect-
icide-
treated 
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Indoor residual spraying§ and 
long-lasting insecticidal nets
Insecticide-treated
nets
Focal indoor residual spraying
[A: are the above
position/time sensitive?]
Figure 2: Trend (blue line) in malaria case numbers in Bhutan, 1965–2014
*With dichlorodiphenyltrichloroethane (DDT). †With deltamethrin. ‡One round per year. §Two rounds per year.
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Farmers were infected more than any other occupation 
group, accounting for more than half of the 961 cases in 
2006 (table 2). A similar trend continued until 2012. 
However, since 2013, labourers have been infected more 
than other occupations, accounting for 29 (60%) of 48 cases 
in 2013 and 20 (44%) of 45 cases in 2014 (table 2). More 
than half of all cases in all years were in the 20–39 years 
age group and in men, for both types of infection (appendix 
pp 2–3).
The Global Fund to Fight AIDS, Tuberculosis and 
Malaria was the main donor supporting the Bhutan 
malaria programme. The highest amount was provided 
in the 2009–10 ﬁ nancial year by the Global Fund, 
amounting to US$1·23 million (73%) of the total 
$1·7 million. The Royal Government of Bhutan 
contribution was $0·17 million (12% of the total 
$1·4 million) in the 2008–09 ﬁ nancial year but increased 
to $0·22 million (32% of the total $0·7 million) in the 
2012–13 ﬁ nancial year. Overall, the total funds provided 
to the VDCP decreased from the 2009–10 to 2012–13 
ﬁ nancial years, but increased again in the 2013–14 
ﬁ nancial year (table 3).
International funding was used solely for preventive and 
control measures, and ranged between $0·5 million in 
2006 and $0·02 million in 2014 (appendix p 4). Most of the 
money was spent on the purchase of long-lasting 
insecticidal nets, with more than $0·45 million (89%) of 
the total spent on procuring these nets in 2006. The 
proportion of money spent on buying drugs fell from 1·4% 
($0·07 million) in 2006 to just 0·08% ($15·34 million) in 
2014. The proportionate cost of rapid diagnostic tests 
increased from 7·8% ($0·04 million of $0·5 million) of 
total costs in 2006 to 29·4% ($0·02 million of $0·05 million) 
in 2007 and fell again to 16·4% ($0·01 million) in 2008. 
There was a further reduction in 2009 (to 6·1%; 
$0·009 million of $0·2 million) but it increased gradually 
to reach 11% ($0·002 million of $0·02 million) in 2014. 
Other commodities, such as pumps for spraying chemicals 
for indoor residual spraying, and microscopes, were also 
purchased in diﬀ erent years (appendix p 4).
2006 2007 2008 2009 2010 2011 2012 2013 2014
Cases in the Bhutanese population
Overall 1751 744 314 883 410 172 64 18 21
P falciparum 733 (42%) 274 (37%) 129 (41%) 433 (49%) 137 (33%) 83 (48%) 31 (48%) 8 (44%) 11 (52%)
Pvivax 895 (52%) 384 (52%) 142 (45%) 374 (42%) 239 (58%) 78 (45%) 31 (48%) 10 (56%) 10 (48%)
Mixed 124 (7%) 86 (12%) 43 (14%) 76 (9%) 34 (8%) 11 (6%) 2 (3%) 0 0
Cases in foreign nationals residing in Bhutan
Overall 116 49 16 89 26 22 18 27 21
P falciparum 39 (34%) 14 (29%) 7 (44%) 41 (46%) 3 (12%) 4 (18%) 2 (11%) 5 (19%) 3 (14%)
P vivax 68 (59%) 30 (61%) 7 (44%) 39 (44%) 22 (85%) 14 (64%) 16 (89%) 21 (78%) 18 (69%)
Mixed 9 (8%) 5 (10%) 2 (13%) 9 (10%) 1 (4%) 15 (8%) 0 1 (4%) 0
Cases in foreign nationals who are daily visitors to Bhutan 
Overall 408 60 32 126 29 45 24 3 3
P falciparum 255 (63%) 28 (47%) 18 (56%) 99 (79%) 14 (48%) 35 (78%) 14 (58%) 1 (33%) 2 (67%)
P vivax 139 (42%) 26 (43%) 13 (41%) 24 (19%) 10 (35%) 10 (22%) 10 (42%) 2 (67%) 1 (33%)
Mixed 14 (3%) 6 (10%) 1 (3%) 3 (2%) 5 (17%) 0 0 0 0
Total deaths
Overall 4 1 2 4 2 1 1 0 0
P falciparum 3 (75%) 0 1 (50%) 3 (75%) 0 1 (100%) 1 (100%) 0 0
Mixed 1 (25%) 1 (100%) 1 (50%) 1 (25%) 2 (100%) 0 0 0 0
Malaria indicators
Population at risk 135 281 137 445 139 645 141 879 144 149 146 455 148 799 151 179 153 598
Long-lasting insecticidal 
nets
93 269 7413 9063 20 963 99 697 8942 11 041 99 617 7086
Long-lasting insecticidal 
nets per person
1·44 ·· ·· ·· 1·45 ·· ·· 1·51 ··
Blood sample collection 66 079 51 446 47 566 62 496 54 617 44 481 42 512 31 632 30 691
Malaria test positivity 
rate, %
2·8% 1·5% 0·7% 1·6% 0·8% 0·4% 0·2% 0·1% 0·1%
Annual malaria 
incidence per 
1000 population
12·9 5·4 2·2 6·2 2·8 1·2 0·4 0·1 0·1
Data are n or n (%), unless otherwise indicated. P falciparum=Plasmodium falciparum. P vivax=Plasmodium vivax.
Table 1:  Trends in malaria infection and indicators in Bhutan, 2006–14
See Online for appendix
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Discussion
During the study period (2006–14) the number of 
P falciparum and P vivax malaria cases has decreased in 
Bhutan. This reduction corresponded with the mass 
distribution of long-lasting insecticidal nets and scaling up 
of indoor residual spraying, whereas other services such as 
diagnosis and treatment did not change during the study 
period. Cases dropped substantially following mass 
distribution of long-lasting insecticidal nets in 2006. 
However, cases resurged in 2009 and 2010, possibly 
because of the waning eﬀ ect of the impregnated insecticide 
in the ﬁ bres of the nets. Reductions in malaria cases 
occurred and were maintained once new long-lasting 
insecticidal nets were distributed in 2010 and 2013. This 
success could be attributed, at least in part, to robust GIS-
based surveillance systems that are in place, aligning with 
the global and regional strategies to eliminate malaria.15,16
This analysis suggests that the greatest threat to 
successful elimination eﬀ orts for Bhutan is importation 
of malaria, especially from India and other nearby 
countries. The two Indian states of Assam and West 
Bengal, which both border Bhutan, report the highest 
malaria burden in India.17–21 The areas adjoining the 
international border in India are forested and are 
inhabited by indigenous people with poor access to 
Figure 3: Changes in types of malaria infection, treatment, and preventive measures in Bhutan, 2006–14
P falciparum=Plasmodium falciparum. P vivax=Plasmodium vivax.
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 2006 
(n=1973)
2007 
(n=798)
2008 
(n=322)
2009 
(n=968)
2010 
(n=424)
2011 
(n=217)
2012 
(n=99)
2013 
(n=48)
2014 
(n=45)
Business person 68 (4%) 23
(3%)
14
(4%)
27
(3%)
6
(1%)
7
(3%)
2
(2%)
3
(6%)
2
(4%)
Farmer 1143
(58%)
452
(57%)
158
(49%)
410
(42%)
201
(47%)
83
(38%)
28
(28%)
7
(15%)
12
(27%)
Government 
employee
76
(4%)
30
(4%)
24
(7%)
34
(4%)
20
(5%)
19
(9%)
6
(6%)
2
(4%)
3
(7%)
Housewife 0 0 0 119
(12%)
35
(8%)
16
(7%)
13
(13%)
1
(2%)
0
Labourer 160
(8%)
77
(10%)
25
(8%)
69
(7%)
41
(10%)
22
(10%)
29
(29%)
29
(60%)
20
(44%)
Monk 9
(1%)
17
(2%)
4
(1%)
6
(1%)
4
(1%)
1
(1%)
0 0 0
Armed forces 177
(7%)
53
(7%)
30
(9%)
31
(3%)
17
(4%)
12
(6%)
2
(2%)
1
(2%)
1
(2%)
Student 340
(17%)
146
(18%)
67
(21%)
272
(28%)
100
(24%)
57
(26%)
19
(19%)
5
(10%)
7
(16%)
Data are n (%).
Table 2: Occupations of patients with malaria infection in Bhutan, 2006–14
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Indian health facilities and services. These areas are 
subject to ethnic violence, which can impede health 
services eﬀ orts.22 A strategy to address cross-border 
malaria with India is crucial to maintain the gains that 
have been achieved by Bhutan so far. Emigrants entering 
and staying overnight in Bhutan usually undergo blood 
examination for malaria parasites. However, day visitors 
do not undergo such a screening process, and therefore 
pose a substantial risk of onward transmission to the 
local population.23 A potential risk of transmission of 
malaria across the borders by infected mosquitoes also 
exists, in view of the very close proximity of villages on 
both sides of the international border.
International donors were the major contributors to 
control and preventive measures, with funds spent on 
procuring antimalarial drugs, long-lasting insecticidal 
nets, indoor residual spraying, rapid diagnostic test kits, 
microscopes, and chemicals and pumps for indoor 
residual spraying. Funds from the Royal Government of 
Bhutan have mainly been used to pay the salaries of the 
oﬃ  cials working in the national programme, to run the 
oﬃ  ces, and for purchasing fuel for vehicles. International 
funding has allowed the ratio of one long-lasting 
insecticidal net per person to better the WHO-
recommended ratio of one long-lasting insecticidal net 
per two people for malaria-endemic areas with low 
transmission.24 This eﬀ ort aims to interrupt local malaria 
transmission by mosquitoes despite a continued presence 
of malaria vectors and importation of parasites.25 Recent 
prospective research has conﬁ rmed high coverage of 
long-lasting insecticidal nets in Bhutan with regular use.26
Bhutan received major funding from the Global Fund 
in grant round 4 (US$1·3 million) and grant round 7 
(US$1·6 million) and from the Global Fund Transitional 
Funding Mechanism ($0·8 million).7 The average 
international donor support worldwide to malaria-
endemic countries for malaria control was less than 
$1 per person per year in 2007.27 The corresponding ﬁ gure 
for Bhutan was $2·2 per person per year, which is more 
than the $0–1 per person per year for 2009.28 With the 
decreasing burden of malaria, international support will 
probably wane, exerting pressure on the Royal 
Government of Bhutan exchequer to fund malaria 
elimination activities. However, to maintain universal 
coverage of long-lasting insecticidal nets post-elimination, 
the Royal Government of Bhutan might need to consider 
two modalities through public–private partnership with 
cost sharing and social marketing of long-lasting 
insecticidal nets.
This study had some limitations. The cost calculations 
did not include the cost of expired drugs and rapid 
diagnostic tests, nor the cost of training malaria 
technicians or of quality assurance programmes. 
Furthermore, the cost analysis was restricted to long-
lasting insecticidal nets and indoor residual spraying 
because no information could be obtained about other 
costs, such as the costs of buildings and equipment. The 
treatment of malaria was provided by physicians and 
other relevant health workers so these costs could not be 
included in the study because of diﬃ  culties in calculating 
the proportion of their time involved in providing 
treatments. The underlying cause of deaths from malaria 
could not be analysed because data were not recorded in 
the surveillance system.
In conclusion, the results of this study show that the 
malaria burden in Bhutan fell substantially during the 
study period, with high coverage of long-lasting 
insecticidal nets in the country. This study identiﬁ ed four 
foreseeable challenges that need national attention to 
maintain a malaria-free status in Bhutan after 
elimination. First, importation of malaria, especially 
from India, necessitates coordinated malaria control 
activities between Bhutan and India. Second, protection 
of the population in the endemic districts will necessitate 
complete coverage with long-lasting insecticidal nets and 
indoor residual spraying. Third, exploration of local 
funding modalities post-elimination will be needed in 
the event of a reduction in international funding. Last, 
initiation of public–private partnerships through cost 
sharing and social marketing of long-lasting insecticidal 
nets to maintain universal coverage of at-risk populations 
should be explored.
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2008–09 2009–10 2010–11 2011–12 2012–13 2013–14
Royal Government of Bhutan $0·17 (12%) $0·21 (12%) $0·20 (26%) $0·26 (29%) $0·22 (32%) $0·20 (21%)
Global Fund to Fight AIDS, 
Tuberculosis and Malaria
$1·0 (73%) $1·23 (73%) $0·38 (49%) $0·42 (47%) $0·28 (40%) $0·60 (63%)
Government of India $0·17 (12%) $0·19 (11%) $0·17 (22%) $0·16 (18%) $0·18 (26%) $0·14 (14%)
WHO $0·04 (3%) $0·05 (3%) $0·02 (3%) $0·05 (6%) $0·02 (3%) $0·01 (2%)
Total $1·4 $1·7 $0·78 $0·9 $0·7 $0·95
Data are millions of US$ (%).
Table 3: Funding source for various malaria control activities in Bhutan
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